Phase 3 Depression and Anxiety Trial, Recruiting NCT07076407 Sponsor: Xenon Pharmaceuticals Inc. Condition: Depression and Anxiety
Back to Depression And Anxiety

Phase 3 Depression and Anxiety Trial, Recruiting

NCT07076407
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 74 years old, and your first episode of major depression started before you were 50 years old
  • Your Body Mass Index (BMI) is 40 or below
  • You have been formally diagnosed with major depressive disorder (MDD) and are currently going through a depressive episode, confirmed through a structured interview with a clinician
  • Your current depressive episode has been ongoing for at least 6 weeks but no longer than 24 months

Who may not be able to join:

  • You have a main mood disorder diagnosis other than major depressive disorder (MDD)
  • You have a history of MDD with psychosis or catatonia, MDD with mixed features, Bipolar I or II disorder, obsessive-compulsive disorder, schizophrenia, or other psychotic disorders
  • You currently have certain conditions including: seasonal depression, depression linked to pregnancy or menopause, PTSD, antisocial or borderline personality disorder, panic disorder or agoraphobia, or ADHD with unstable symptoms or treated with stimulant medication during your current depressive episode (confirm with trial site)
  • You have had a drug or alcohol use disorder (not including tobacco) within the past 12 months
  • You have had active suicidal plans or intent in the past 6 months, suicidal behaviour in the past 2 years, or more than one suicide attempt after the age of 24
  • You have deliberately harmed yourself (without suicidal intent) in the past 12 months
  • You have taken antidepressants or certain other medications (including benzodiazepines) recently — the exact timeframe depends on the medication, but is generally within the past 2–4 weeks before joining the trial (confirm with trial site)
  • You have tried 2 or more antidepressant medications at appropriate doses during your current depressive episode without them working
  • You have certain physical health conditions that could interfere with the study (confirm with trial site)
  • You are currently pregnant, breastfeeding, or planning to become pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Xenon Pharmaceuticals Inc.
Registry
ClinicalTrials.gov
Start date
8 July 2025
Est. completion
1 May 2027

Where this trial is recruiting

🇫🇮 Finland 🇵🇱 Poland 🇷🇴 Romania 🇸🇰 Slovakia 🇪🇸 Spain 🇺🇸 United States

Primary endpoints

Change from baseline in the Hamilton Depression Rating Scale, 17-item (HAMD-17) score at Week 6

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov